#bone marrow transplant

Preclinical findings highlight bacterial groups that influence the risk for graft-versus-host-disease in blood cancer transplant patients.

Researchers discover antibodies to block common respiratory viruses that put bone marrow and stem cell transplant patients at risk.

A small group of adults in remission had persisting mutations that predicted their risk of death from having the cancer return.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

Responses to the off-the-shelf treatment were observed in 95% of patients.

People who followed a protective diet and those on a standard hospital diet had a similar likelihood of infections.

Research at #ASH22 calls into question longstanding assumptions and charts a path for gentler therapies.

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

Helping young adult cancer survivors pay down their staggering medical bills and catch up to their peers in education and careers

An experimental drug saved his life and inspire him to connect others with cancer to bone marrow transplants and clinical trials.

This two-time cancer survivor and former health reporter believes “pre-habilitation” can prepare you for any health crisis.

With omicron surging in February, Suleika Jaouad’s husband Jon Batiste couldn’t be with her in the hospital.

Grammy Award winner Jon Batiste married author Suleika Jaouad a day before a bone marrow transplant to treat her acute myeloid leukemia.

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

A new clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia. Here’s how to get more info.

New guidelines from NCCN offer clarity and consensus on how best to address and treat a common side effect of stem cell transplants.